Quantinno Capital Management’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.26M Buy
326,646
+275,157
+534% +$6.32M 0.01% 1418
2026
Q2
$1.14M Buy
51,489
+32,192
+167% +$599K ﹤0.01% 2447
2026
Q1
$350K Buy
19,297
+6,704
+53% +$116K ﹤0.01% 2946
2025
Q4
$246K Buy
12,593
+254
+2% +$4.81K ﹤0.01% 2947
2025
Q3
$156K Buy
+12,339
New +$141K ﹤0.01% 2822

Other funds holding DYN

Quantinno Capital Management's DYN Position: Q3 2026 in Review

Quantinno Capital Management increased its Dyne Therapeutics (DYN) stake by 534% in Q3 2026, buying an estimated $6.32M and bringing the position to 326,646 shares worth $5.26M. The position accounts for 0.01% of the portfolio, ranked #1418.

Quantinno Capital Management first reported a position in DYN in Q3 2025 and has held it in 5 quarters since. 270 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

  • Quantinno Capital Management held 326,646 shares of Dyne Therapeutics worth $5.26M as of Q3 2026.
  • Quantinno Capital Management bought 275,157 Dyne Therapeutics shares in Q3 2026, an estimated $6.32M.
  • Dyne Therapeutics made up 0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1418 holding.
  • Quantinno Capital Management first reported a position in Dyne Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • 270 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.